AKEBIA THERAPEUTICS, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
AKEBIA THERAPEUTICS, INC. (AKBA) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$56.36 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2015-03-04
- AKEBIA THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-12-31 was -$5.10K.
- AKEBIA THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-09-30 was -$43.04K.
- AKEBIA THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was -$56.36K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$5.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | -$48.14K derived: sum of 2 quarters · filed 2015-03-04 | -$56.36K 10-K · filed 2015-03-04 | |
| 2014-09-30 | -$43.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$51.26K 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | -$8.22K 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |